Clinical Trials Browser

Interventional × Tissue Plasminogen Activator × Other solid neoplasm × Clear all

NCT02492477 2018-08-21

TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients

Phase 1 Terminated

Other solid neoplasm

Adjuvant Chemotherapy

NCT00086723 2012-06-11

In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer

Phase 1/2 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific